Emily O’Connor has been with Gilead Sciences for a little over a year, but she has already brought about huge transformations. (She hit the ground running with more than 16 years’ experience in healthcare marketing.) At Gilead, O’Connor has developed U.S. commercial strategy for market preparedness and led the launch of a first-in-class immunotherapy for hematological malignancies. At the same time, she has begun to build a passionate and collaborative culture at Gilead Oncology. Outside of work, O’Connor spends much of her time with her children Callum (5 years old) and Isabelle (3) and their dog, Ralph (10).